BlackRock Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-694
Closed -$715K 3803
2015
Q2
$715K Hold
694
﹤0.01% 1908
2015
Q1
$988K Hold
694
﹤0.01% 1568
2014
Q4
$971K Sell
694
-2
-0.3% -$2.89K ﹤0.01% 1519
2014
Q3
$852K Sell
696
-74
-10% -$106K ﹤0.01% 1538
2014
Q2
$1.4M Sell
770
-18
-2% -$24K ﹤0.01% 1302
2014
Q1
$1.28M Sell
788
-717
-48% -$1.5M ﹤0.01% 1383
2013
Q4
$1.94M Buy
1,505
+7
+0.5% +$11.2K ﹤0.01% 1200
2013
Q3
$3.01M Buy
+1,498
New +$2.78M ﹤0.01% 1080

Other funds holding HSTO

BlackRock Advisors's HSTO Position: Q3 2015 in Review

BlackRock Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2015, closing a stake of 694 shares — an estimated $715K sold.

BlackRock Advisors first reported a position in HSTO in Q3 2013 and held it in 8 quarters. The position peaked at $3.01M in Q3 2013. 37 funds tracked by Wall St. Rank hold HSTO as of Q3 2015.

  • BlackRock Advisors reported no remaining Histogen Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • BlackRock Advisors sold 694 Histogen Inc. Common Stock shares in Q3 2015, an estimated $715K.
  • BlackRock Advisors first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 8 quarters.
  • BlackRock Advisors's Histogen Inc. Common Stock position peaked at $3.01M in Q3 2013.
  • 37 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2015.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.